相关实验视频
Updated: Jan 11, 2026

10:44
Influenza A Virus Studies in a Mouse Model of Infection
Published on: September 7, 2017
29.6K
为下一次流感大流行做好准备:疫苗进展,挑战和前景
1National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
China CDC weekly
|November 19, 2025
概括
新型流感菌株,如H5N1,由于免疫力有限和病毒突变,构成流行病威胁. 开发广泛保护的疫苗至关重要,但具有挑战性,需要先进的技术来应对流行病的准备.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 流感大流行源于缺乏人口免疫力的新型病毒亚型.
- 包括牛在内的哺乳动物中的H5N1病毒循环和人类感染突出显示了新出现的威胁.
- 抗击流行病的准备依赖于提供广泛保护的疫苗,以抵御各种流感菌株.
研究的目的:
- 为了应对开发有效的流行性流感疫苗的挑战.
- 突出需要针对不断演变的流感菌株进行广泛保护的疫苗.
- 强调在疫苗技术和生产方面继续进行研究的重要性.
主要方法:
- 审查当前流感病毒特征和流行病潜力.
- 对开发通用流感疫苗的挑战进行分析.
- 评估疫苗生产,生物信息学和人工智能的最新技术进步.
主要成果:
- 新型流感菌株,如H5N1,显示出日益增长的流行病潜力.
- 流感病毒的快速突变率和遗传重组构成了疫苗开发的重大障碍.
- 技术的进步正在加速流行病疫苗开发能力.
结论:
- 有效的流行病准备取决于开发具有广泛功效的疫苗.
- 克服挑战需要增强疫苗技术,更快的生产和更广泛的菌株覆盖.
- 持续的研究对于应对新型流感菌株的持续威胁至关重要.
相关概念视频
Vaccinations
51.2K
Overview
51.2K
Microorganisms in Medicine and Therapeutics
920
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
920
Viral Recombination
24.9K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.9K
Viral Mutations
39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K

